Form 4 for ABT Abbott Laboratories
Accepted 2021-12-28 00:00:00 ET · period of report 2021-12-23 · accession 0001415889-21-006265 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-28 | 2021-12-23+ | ABT | Wainer Andrea F | EVP | M - OptEx | $41.62 | +16.0K | 62.8K | +34% | +$666.0K |
| DM | 2021-12-28 | 2021-12-23+ | ABT | Wainer Andrea F | EVP | S - Sale+OE | $140.47 | -16.0K | 49.8K | -24% | -$2.25M |
| DM | 2021-12-28 | 2021-12-23+ | ABT | Wainer Andrea F | EVP | M - OptEx | $0.00 | -16.0K | 11.2K | -59% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2021-12-27 | M | A | 3,000 | $47.00 | 52,782 | D | — | — | |
| 2 | Common | Common shares without par value | 2021-12-23 | M | A | 3,000 | $47.00 | 52,782 | D | — | — | |
| 3 | Common | Common shares without par value | 2021-12-23 | S | D | 13,000 | $140.00 | 49,782 | D | — | — | |
| 4 | Common | Common shares without par value | 2021-12-23 | M | A | 10,000 | $38.40 | 62,782 | D | — | — | |
| 5 | Common | Common shares without par value | 2021-12-27 | S | D | 3,000 | $142.50 | 49,782 | D | — | — | |
| 6 | Derivative | Option (right to buy) | 2021-12-27 | M | D | 3,000 | $0.00 | 8,226 | D | $47.00 · 2018-02-20 to 2025-02-19 | 3,000 Common Shares | (F1) Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |
| 7 | Derivative | Option (right to buy) | 2021-12-23 | M | D | 10,000 | $0.00 | 5,000 | D | $38.40 · 2019-02-19 to 2026-02-18 | 10,000 Common Shares | (F1) Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |
| 8 | Derivative | Option (right to buy) | 2021-12-23 | M | D | 3,000 | $0.00 | 11,226 | D | $47.00 · 2018-02-20 to 2025-02-19 | 3,000 Common Shares | (F1) Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |